Cross-sectional study found anti-TPO antibodies in 38% of hypothyroid patients, highlighting autoimmune thyroiditis prevalence.
Introduction: Hypothyroidism is a common endocrine disorder with autoimmune thyroiditis increasing as a major cause, especially in iodine-sufficient areas. Anti-thyroid peroxidase (anti-TPO) antibodies are important markers of autoimmune thyroid disease. The objective of this study to determine the prevalence of anti-TPO antibodies in hypothyroid patients and their correlation with the type of hypothyroidism, age, gender, and clinical presentation. Methods: This analytical cross-sectional study was conducted among 73 hypothyroid patients attending the OPD and medical ward of Western Regional Hospital (WRH), a tertiary care centre in Gandaki Province. Demographic and clinical data were collected. Laboratory assessments included thyroid function tests and anti-TPO levels using chemiluminescence immunoassay. Descriptive and inferential statistics were applied using SPSS v27. Results: Among 73 participants (mean age 42.1 ± 12.07 years), 81% were female. Anti-TPO antibodies were positive in 38% of patients. Among patients with overt hypothyroidism, 41% were anti-TPO positive, while 36% of subclinical hypothyroidism patients had anti-TPO positivity. No statistically significant associations were found between anti-TPO status and gender (p=0.821), type of hypothyroidism (p=0.666), or age group (p=0.24). Likewise, the common presenting signs and symptoms did not have statistically significant association with the TPO positivity status. Conclusion: Over one-third of hypothyroid patients had anti-TPO antibody positivity, with a slightly higher prevalence in overt hypothyroidism. However, demographic and clinical variables did not significantly correlate with antibody status.
No takes yet. Share an insight, caveat, or question.
Bastola et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: